BrainStorm Cell Therapeutics
BCLI
#10932
Rank
S$13.56 M
Marketcap
S$1.23
Share price
1.16%
Change (1 day)
45.23%
Change (1 year)

Earnings for BrainStorm Cell Therapeutics (BCLI)

Earnings in 2026 (TTM): -S$13.57 Million

According to BrainStorm Cell Therapeutics's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -S$13.21 Million, an increase over its 2024 earnings that were of -S$14.89 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for BrainStorm Cell Therapeutics from 2003 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -S$13.57 Million2.73%
2025 -S$13.21 Million-11.32%
2024 -S$14.89 Million-32.39%
2023 -S$22.03 Million-29.18%
2022 -S$31.1 Million-0.74%
2021 -S$31.33 Million-23.12%
2020 -S$40.75 Million36.8%
2019 -S$29.79 Million66.71%
2018 -S$17.87 Million181.66%
2017 -S$6.35 Million-0.6%
2016 -S$6.39 Million-41.31%
2015 -S$10.88 Million-8.22%
2014 -S$11.85 Million89.74%
2013 -S$6.25 Million42.27%
2012 -S$4.39 Million-12.45%
2011 -S$5.02 Million63.04%
2010 -S$3.08 Million35.52%
2009 -S$2.27 Million-48.99%
2008 -S$4.45 Million-44.39%
2007 -S$8 Million
2005 -S$4.15 Million-91.44%
2004 -S$48.4 Million94007.62%
2003 -S$0.06 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Biogen
BIIB
S$1.29 B-9,712.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
-S$2.51 Billion 18,480.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Seagen
SGEN
-S$1.02 Billion 7,413.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
-S$1.15 Billion 8,396.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
S$0.19 B-1,535.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
-S$0.33 Billion 2,328.14%๐Ÿ‡บ๐Ÿ‡ธ USA